SYSMEX CORP.UNSP.ADR 1/2 Total Liabilities
SYSMEX CORP.UNSP.ADR 1/2 total liabilities. Based on the latest financial reports, SYSMEX CORP.UNSP.ADR 1/2 (0YX0) has total liabilities worth €186.25 Billion EUR (≈ $217.75 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See SYSMEX CORP.UNSP.ADR 1/2 (0YX0) defensive interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of SYSMEX CORP.UNSP.ADR 1/2 (2022–2025)
Total liabilities of SYSMEX CORP.UNSP.ADR 1/2 from 2022 to 2025. This chart illustrates how SYSMEX CORP.UNSP.ADR 1/2's total liabilities have evolved over time, based on quarterly financial data. Check 0YX0 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SYSMEX CORP.UNSP.ADR 1/2 Competitors by Total Liabilities
The table below lists competitors of SYSMEX CORP.UNSP.ADR 1/2 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kingnet Network Co Ltd
SHE:002517
|
China | CN¥3.01 Billion |
|
Iridium Communications Inc
NASDAQ:IRDM
|
USA | $2.09 Billion |
|
Riot Platforms, Inc.
NASDAQ:RIOT
|
USA | $1.08 Billion |
|
United Internet AG NA
XETRA:UTDI
|
Germany | €6.67 Billion |
|
Taiwan High Speed Rail Corp
TW:2633
|
Taiwan | NT$320.53 Billion |
|
L&K Engineering Co Ltd
TW:6139
|
Taiwan | NT$59.33 Billion |
|
Samsung Securities
KO:016360
|
Korea | ₩97.52 Trillion |
|
Beijing Yanjing Brewery Co Ltd
SHE:000729
|
China | CN¥8.05 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down SYSMEX CORP.UNSP.ADR 1/2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 0YX0 total assets.
Liquidity & Leverage Metrics
SYSMEX CORP.UNSP.ADR 1/2 Total Liabilities Ratios Explained
SYSMEX CORP.UNSP.ADR 1/2 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SYSMEX CORP.UNSP.ADR 1/2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SYSMEX CORP.UNSP.ADR 1/2 (2022–2025)
The table below shows the annual total liabilities of SYSMEX CORP.UNSP.ADR 1/2 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €200.73 Billion ≈ $234.68 Billion |
+7.91% |
| 2024-03-31 | €186.02 Billion ≈ $217.48 Billion |
+30.34% |
| 2023-03-31 | €142.72 Billion ≈ $166.85 Billion |
+5.99% |
| 2022-03-31 | €134.65 Billion ≈ $157.42 Billion |
-- |
About SYSMEX CORP.UNSP.ADR 1/2
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more